发布求助
文献互助 智能选刊 最新文献

International Journal of Healthcare Technology and Management最新文献

筛选
英文 中文
A healthy lifestyle app for older adults with diabetes and hypertension: usability assessment 针对糖尿病和高血压老年人的健康生活方式应用程序:可用性评估
IF 1
International Journal of Healthcare Technology and Management Pub Date : 2017-12-23 DOI: 10.1504/IJHTM.2017.10009747
Jenna Smith-Turchyn, Janelle Gravesande, G. Agarwal, D. Mangin, D. Javadi, J. Peter, F. Parascandalo, L. Dolovich, J. Richardson
{"title":"A healthy lifestyle app for older adults with diabetes and hypertension: usability assessment","authors":"Jenna Smith-Turchyn, Janelle Gravesande, G. Agarwal, D. Mangin, D. Javadi, J. Peter, F. Parascandalo, L. Dolovich, J. Richardson","doi":"10.1504/IJHTM.2017.10009747","DOIUrl":"https://doi.org/10.1504/IJHTM.2017.10009747","url":null,"abstract":"Risk factor modification interventions using mobile health technology have been shown to be effective in managing non-communicable lifestyle related conditions. The objective of this study was to explore how older adults with type 2 diabetes and hypertension use an online app developed to help manage these conditions. Usability testing was conducted on the TAPESTRY-CM Healthy Lifestyle App, an online self-management application. This included an online session, using a cognitive interviewing approach, and semi-structured interviews at various times. Qualitative content analysis was performed as sessions were completed using coding and category formation. All participants commented positively on app content. Suggestions for improvement were given in regard to app content and layout. This study provides strong support for initial use of this app. Results of this study will be used to improve the app prior to conducting larger scale effectiveness trials or using it in clinical practice.","PeriodicalId":51933,"journal":{"name":"International Journal of Healthcare Technology and Management","volume":"16 1","pages":"250"},"PeriodicalIF":1.0,"publicationDate":"2017-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66972814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Ontology driven meta-modelling of clinical documents 临床文献本体驱动的元建模
IF 1
International Journal of Healthcare Technology and Management Pub Date : 2017-12-23 DOI: 10.1504/IJHTM.2017.10009750
Shreya M. Banerjee, A. Sarkar
{"title":"Ontology driven meta-modelling of clinical documents","authors":"Shreya M. Banerjee, A. Sarkar","doi":"10.1504/IJHTM.2017.10009750","DOIUrl":"https://doi.org/10.1504/IJHTM.2017.10009750","url":null,"abstract":"In recent days, distinct healthcare information systems use and exchange electronic clinical documents enormously. Further, modern technologies, such as connected home monitoring devices, incorporate contextual awareness into clinical documents. Besides this, today's healthcare domain is driven by emergence of new roles played by related stakeholders. Consequently, there is a need in healthcare information systems to achieve common semantic interpretation of clinical documents so that, 1) those can be exchanged among healthcare information systems meaningfully; 2) personalised document view in a specific context can be achieved effectively. To address these issues in this paper, an ontology driven meta-model for clinical documents is proposed. The proposed conceptualisation is implemented in an ontology editorial tool Protege and illustrated using a case study based on e-prescription. Further, the specification is transformed towards JSON (Java Script Object Notation Schema) schema for demonstration of its practical utility.","PeriodicalId":51933,"journal":{"name":"International Journal of Healthcare Technology and Management","volume":"16 1","pages":"271"},"PeriodicalIF":1.0,"publicationDate":"2017-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46559654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Value chain building and business model in the mobile device healthcare industry - the case of China 移动设备医疗行业的价值链构建与商业模式——以中国为例
IF 1
International Journal of Healthcare Technology and Management Pub Date : 2017-10-24 DOI: 10.1504/IJHTM.2017.10008507
Jie Zhang
{"title":"Value chain building and business model in the mobile device healthcare industry - the case of China","authors":"Jie Zhang","doi":"10.1504/IJHTM.2017.10008507","DOIUrl":"https://doi.org/10.1504/IJHTM.2017.10008507","url":null,"abstract":"Although mobile device healthcare (MDH) industry is developing fast, people do not have a deep understanding of its value chain, and further, its business model. In this paper, I analyse the development of The MDH industry in China, then clarify the total market scale of MDH. Based on these, I discuss key segments in the value chain of MDH industry and unveil the business model of MDH firms. After that, the change brought by the mobile devices for the traditional healthcare industry is investigated. Finally, six cases of MDH firms in China are raised and discussed in detail.","PeriodicalId":51933,"journal":{"name":"International Journal of Healthcare Technology and Management","volume":"16 1","pages":"59"},"PeriodicalIF":1.0,"publicationDate":"2017-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44336958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
China's legal framework for pharmaceutical products: challenges and opportunities for EU companies 中国医药产品法律框架:欧盟企业面临的挑战与机遇
IF 1
International Journal of Healthcare Technology and Management Pub Date : 2017-10-24 DOI: 10.1504/IJHTM.2017.10006645
Pamela Lattanzi, Federica Monti, Zhao Xu
{"title":"China's legal framework for pharmaceutical products: challenges and opportunities for EU companies","authors":"Pamela Lattanzi, Federica Monti, Zhao Xu","doi":"10.1504/IJHTM.2017.10006645","DOIUrl":"https://doi.org/10.1504/IJHTM.2017.10006645","url":null,"abstract":"It is unanimously recognised in the literature that although the Chinese pharmaceutical market offers huge opportunities to European industry, it poses several challenges regarding compliance with the laws governing this sector. Because of the different legal traditions, a peculiar public health history and culture, and a different system of healthcare, EU companies have faced many barriers in accessing the Chinese pharmaceutical market over the years. In order to provide a better understanding of the China's regulatory landscape and its emerging trends, the article focuses on three critical legal topics, which are relevant for the business of EU pharmaceutical companies in the Chinese market: drug registration, drug distribution system, and IP rights protection.","PeriodicalId":51933,"journal":{"name":"International Journal of Healthcare Technology and Management","volume":"16 1","pages":"128-154"},"PeriodicalIF":1.0,"publicationDate":"2017-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42371425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Chinese pharmaceuticals: does sub-national marketisation matter? Evidence of cross-province acquisitions by Guangdong pharmaceutical firms 中国制药：跨国市场化重要吗？广东医药企业跨省收购的证据
IF 1
International Journal of Healthcare Technology and Management Pub Date : 2017-10-24 DOI: 10.1504/IJHTM.2017.087596
Manli Huang, Huiru Zhang, Antonio Angelino
{"title":"Chinese pharmaceuticals: does sub-national marketisation matter? Evidence of cross-province acquisitions by Guangdong pharmaceutical firms","authors":"Manli Huang, Huiru Zhang, Antonio Angelino","doi":"10.1504/IJHTM.2017.087596","DOIUrl":"https://doi.org/10.1504/IJHTM.2017.087596","url":null,"abstract":"This article assesses the influence of sub-national marketisation on the equity share choice in mergers and acquisitions. Focusing on domestic acquisitions, we examine the relationship between marketisation of the target firm and the acquirer firm's equity share choice by Guangdong (GD) firms in pharmaceuticals. Our sample consists of 53 domestic acquisitions in China of which acquirers are located in GD province and targets are located all over China. Findings confirm that differences exist in equity share choice based on different sub-national marketisation within China. Sub-national marketisation has significant association with equity share in cross-province acquisitions. An acquirer will more likely opt for partial shares in the acquired firm than full shares when acquiring a firm across provinces.","PeriodicalId":51933,"journal":{"name":"International Journal of Healthcare Technology and Management","volume":"16 1","pages":"95"},"PeriodicalIF":1.0,"publicationDate":"2017-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1504/IJHTM.2017.087596","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41859081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Focusing on the Chinese health industry: an empirical enquiry on the TCM listed firms. Is large and private beautiful? 聚焦中国健康产业:中药上市公司的实证研究。大而私密是美丽的吗?
IF 1
International Journal of Healthcare Technology and Management Pub Date : 2017-10-24 DOI: 10.1504/IJHTM.2017.10006769
M. R. D. Tommaso, S. Bonnini, Y. Qi
{"title":"Focusing on the Chinese health industry: an empirical enquiry on the TCM listed firms. Is large and private beautiful?","authors":"M. R. D. Tommaso, S. Bonnini, Y. Qi","doi":"10.1504/IJHTM.2017.10006769","DOIUrl":"https://doi.org/10.1504/IJHTM.2017.10006769","url":null,"abstract":"TCM is a key part of the Chinese healthcare system and TCM industries might play a growing role in the domestic and international markets. This work focuses on TCM listed companies in China. In particular, we study the effect of ownership and size on corporate performance. Multivariate permutation tests on the effects of ownership and size on corporate performance show that among the TCM listed companies, private companies perform better than state-owned ones, while big companies perform better than small ones. Moreover, the study shows that in TCM industry ownership has stronger effects than size on corporate performance.","PeriodicalId":51933,"journal":{"name":"International Journal of Healthcare Technology and Management","volume":"16 1","pages":"77"},"PeriodicalIF":1.0,"publicationDate":"2017-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47455377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Perceptions of health technology assessment knowledge translation in China: a qualitative study on HTA researchers and policy-makers 中国卫生技术评估知识转化的认知:基于卫生技术评估研究者和决策者的质性研究
IF 1
International Journal of Healthcare Technology and Management Pub Date : 2017-10-24 DOI: 10.1504/IJHTM.2017.10008509
Yan Wei, R. Pong, Lizheng Shi, J. Ming, Meng Tang, Yiwei Mao, Wenbin Liu, Yingyao Chen
{"title":"Perceptions of health technology assessment knowledge translation in China: a qualitative study on HTA researchers and policy-makers","authors":"Yan Wei, R. Pong, Lizheng Shi, J. Ming, Meng Tang, Yiwei Mao, Wenbin Liu, Yingyao Chen","doi":"10.1504/IJHTM.2017.10008509","DOIUrl":"https://doi.org/10.1504/IJHTM.2017.10008509","url":null,"abstract":"Although health technology assessment (HTA) has existed in China since the 1980s, the integration of HTA and policy-making is still in its infancy. Knowledge translation (KT) can play an important role in facilitating evidence-based policy-making. This study aims to describe the process of KT from researches to policy-makers and identifying the main determinants of the use of HTA evidence in policy-making in China. Researchers' and health policy-makers' perceptions of HTA KT were identified, using a grounded theory analysis approach. A theoretical framework consisting of four domains emerged to represent researchers' and policy-makers' perceptions of KT from HTA to policy making. Health policy-makers and researchers identified several determinants of KT, including HTA KT processes, alignment between research and decision-making and features of HTA research and health decisions, communication between policy-makers and HTA researchers, and support and resources for KT (organisational support, researchers' and health policy-makers' personal relationships and macro environment support).","PeriodicalId":51933,"journal":{"name":"International Journal of Healthcare Technology and Management","volume":"16 1","pages":"44"},"PeriodicalIF":1.0,"publicationDate":"2017-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49255246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Chinese pharmaceuticals: does sub-national marketization matter? Evidence of cross-province acquisitions by Guangdong firms 中国医药:地方市场化重要吗?广东公司跨省收购的证据
IF 1
International Journal of Healthcare Technology and Management Pub Date : 2017-01-01 DOI: 10.1504/IJHTM.2017.10006561
Manli Huang, Huiru Zhang, Antonio Angelino
{"title":"Chinese pharmaceuticals: does sub-national marketization matter? Evidence of cross-province acquisitions by Guangdong firms","authors":"Manli Huang, Huiru Zhang, Antonio Angelino","doi":"10.1504/IJHTM.2017.10006561","DOIUrl":"https://doi.org/10.1504/IJHTM.2017.10006561","url":null,"abstract":"","PeriodicalId":51933,"journal":{"name":"International Journal of Healthcare Technology and Management","volume":"124 1","pages":"1"},"PeriodicalIF":1.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66973064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Multi-level determinants of tele-healthcare innovations: an Italian case study. 远程医疗创新的多层次决定因素:意大利案例研究。
IF 1
International Journal of Healthcare Technology and Management Pub Date : 2017-01-01 DOI: 10.1504/IJHTM.2017.10008836
S. Barsanti, S. D. Rosis
{"title":"Multi-level determinants of tele-healthcare innovations: an Italian case study.","authors":"S. Barsanti, S. D. Rosis","doi":"10.1504/IJHTM.2017.10008836","DOIUrl":"https://doi.org/10.1504/IJHTM.2017.10008836","url":null,"abstract":"","PeriodicalId":51933,"journal":{"name":"International Journal of Healthcare Technology and Management","volume":"1 1","pages":"1"},"PeriodicalIF":1.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66972753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Introduction of a non-ported peripheral intravenous catheter with multi-use blood control septum offers improvements in the overall efficiency of the procedure and is clinically well accepted 引入无孔外周静脉导管，多用途血液控制隔，提高了手术的整体效率，在临床上被广泛接受
IF 1
International Journal of Healthcare Technology and Management Pub Date : 2016-08-17 DOI: 10.1504/IJHTM.2016.078336
D. M. Cooper, M. Whitfield, D. Newton, J. Chiarella, K. Machaczek
{"title":"Introduction of a non-ported peripheral intravenous catheter with multi-use blood control septum offers improvements in the overall efficiency of the procedure and is clinically well accepted","authors":"D. M. Cooper, M. Whitfield, D. Newton, J. Chiarella, K. Machaczek","doi":"10.1504/IJHTM.2016.078336","DOIUrl":"https://doi.org/10.1504/IJHTM.2016.078336","url":null,"abstract":"Financial challenges that the National Health Service (NHS), England, faces may jeopardise its future. This study evaluated the direct cost of using two different safety peripheral intravenous cannulae (SPIVC) with and without a blood control septum, including the cost of device and clinician time. Observation of 103 cannulations demonstrated a 54 second (29%) time reduction per cannulation with the non-ported SPIVC with multi-use blood control septum (Introcan Safety® 3 B Braun), compared to the standard ported SPIVC (Vasofix® Safety B Braun) (P < 0.05). The direct cost analysis, including clinician time, demonstrated that the introduction of SPIVC with multi-use blood control septum could offer time efficiency savings equivalent to a reduction in average cannulation costs by 25%. 82% of users perceived the insertion of SPIVC with multi-use blood control septum to be easy to use; 82% would choose to use it in clinical practice.","PeriodicalId":51933,"journal":{"name":"International Journal of Healthcare Technology and Management","volume":"15 1","pages":"177"},"PeriodicalIF":1.0,"publicationDate":"2016-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1504/IJHTM.2016.078336","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66971180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信